Suppr超能文献

CKS2介导与M2巨噬细胞相关的肝缺血再灌注损伤后肝细胞癌复发。

CKS2 Mediates Hepatocellular Carcinoma Recurrence After Hepatic Ischemia-Reperfusion Injury Related to M2 Macrophages.

作者信息

Xia Senzhe, Qin Xueqian, Pan Chenggeng, Fan Dingwei, Yang Daqing

机构信息

Department of Comprehensive Surgery, Wenzhou Central Hospital, Wenzhou, People's Republic of China.

Department of Comprehensive Surgery, The Dingli Clinical College of Wenzhou Medical University, Wenzhou, People's Republic of China.

出版信息

J Inflamm Res. 2025 Aug 27;18:11801-11819. doi: 10.2147/JIR.S543147. eCollection 2025.

Abstract

PURPOSE

Hepatocellular carcinoma (HCC) recurrence remains a significant burden on global healthcare. Hepatic ischemia-reperfusion injury (HIRI) is a common complication in liver surgery and may be a contributing factor to HCC recurrence. Nevertheless, the potential mechanism underlying HIRI-induced HCC recurrence has not been fully elucidated. Herein, by combining bioinformatics approaches and basic experimental research, CKS2 was preliminarily identified as a crucial factor involved in HIRI-induced HCC recurrence potentially by modulating M2 macrophages.

METHODS

Through performing Weighted Gene Co-Expression Network Analysis (WGCNA), differential gene expression analysis, and screening for genes associated with disease-free survival (DFS) on large-scale genomics projects including The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO), the pivotal role of CKS2 in HIRI-induced HCC recurrence was determined. The clinical significance, single-cell analysis, immune cell infiltration correlation, functional enrichment, mutation landscape, and drug sensitivity of CKS2 in HCC were further characterized. Finally, CKS2 expression and function were validated through experimental techniques such as flow cytometry, immunohistochemistry, Western blot assay and quantitative real-time PCR (qRT-PCR).

RESULTS

The expression of CKS2 was significantly upregulated in HIRI and HCC tissues and was closely associated with adverse clinical outcomes in HCC patients. There was a positive correlation between CKS2 expression and tumor stemness characteristics. Additionally, high CKS2 expression was strongly linked to M2 macrophage infiltration in HCC tissues. And drug sensitivity analysis indicated that HCC patients with high CKS2 expression were prone to develop drug resistance, complicating clinical anti-tumor treatment. Ultimately, the expression pattern of CKS2 and its correlation with M2 macrophages in HCC were confirmed through experimental validation.

CONCLUSION

CKS2 was identified as a key factor in HIRI-induced HCC recurrence and was critically associated with M2 macrophage infiltration abundance, providing novel insights and a direction for future research.

摘要

目的

肝细胞癌(HCC)复发仍然是全球医疗保健的重大负担。肝缺血再灌注损伤(HIRI)是肝脏手术中的常见并发症,可能是HCC复发的一个促成因素。然而,HIRI诱导HCC复发的潜在机制尚未完全阐明。在此,通过结合生物信息学方法和基础实验研究,初步确定细胞周期蛋白依赖性激酶调节亚基2(CKS2)可能是通过调节M2巨噬细胞参与HIRI诱导HCC复发的关键因素。

方法

通过进行加权基因共表达网络分析(WGCNA)、差异基因表达分析,并在包括癌症基因组图谱(TCGA)和基因表达综合数据库(GEO)在内的大规模基因组学项目中筛选与无病生存期(DFS)相关的基因,确定CKS2在HIRI诱导HCC复发中的关键作用。进一步对CKS2在HCC中的临床意义、单细胞分析、免疫细胞浸润相关性、功能富集、突变图谱和药物敏感性进行了表征。最后,通过流式细胞术、免疫组织化学、蛋白质免疫印迹分析和定量实时聚合酶链反应(qRT-PCR)等实验技术对CKS2的表达和功能进行了验证。

结果

CKS2在HIRI和HCC组织中的表达显著上调,且与HCC患者的不良临床结局密切相关。CKS2表达与肿瘤干性特征呈正相关。此外,高CKS2表达与HCC组织中M2巨噬细胞浸润密切相关。药物敏感性分析表明,CKS2高表达的HCC患者容易产生耐药性,使临床抗肿瘤治疗复杂化。最终,通过实验验证证实了CKS2在HCC中的表达模式及其与M2巨噬细胞的相关性。

结论

CKS2被确定为HIRI诱导HCC复发的关键因素,并且与M2巨噬细胞浸润丰度密切相关,为未来研究提供了新的见解和方向。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验